HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.

Frleta, Davor; Ochoa, Carolyn E; Kramer, Holger B; Khan, Shaukat Ali; Stacey, Andrea R; Borrow, Persephone; Kessler, Benedikt M; Haynes, Barton F et al. · J Clin Invest · 2012

basic_science · Level V

Where this comes from

Abstract

Acute HIV-1 infection results in dysregulated immunity, which contributes to poor control of viral infection. DCs are key regulators of both adaptive and innate immune responses needed for controlling HIV-1, and we surmised that factors elicited during acute HIV-1 infection might impede DC function. We derived immature DCs from healthy donor peripheral blood monocytes and treated them with plasma from uninfected control donors and donors with acute HIV-1 infections. We found that the plasma from patients with HIV specifically inhibited DC function. This suppression was mediated by elevated apoptotic microparticles derived from dying cells during acute HIV-1 infection. Apoptotic microparticles bound to and inhibited DCs through the hyaluronate receptor CD44. These data suggest that targeting this CD44-mediated inhibition by apoptotic microparticles could be a novel strategy to potentiate DC activation of HIV-specific immunity.

Medical subject headings